Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by nozzpackon Dec 17, 2020 9:06am
374 Views
Post# 32126704

Globe Article Gets it Right..Its about Costs

Globe Article Gets it Right..Its about Costs

 

Globe says Aphria-Tilray merger aimed at cutting costs

 

2020-12-17 08:57 ET - In the News

 

The Globe and Mail reports in its Thursday edition that two of Canada's largest cannabis companies are merging in an all-share deal aimed at cutting costs and positioning the combined entity for potential changes to marijuana laws in the United States and Europe.

The Globe's Mark Rendell writes that the merger of Aphria and Tilray, announced Wednesday, is the first major takeover in Canada since recreational cannabis was legalized in 2018.

The combined company, which will continue under the Tilray name, will have the largest cannabis sales footprint in the country and an implied equity valuation of close to $5-billion. Current Aphria shareholders will control roughly 62 per cent of the company.

The Canadian cannabis sector is widely seen as ripe for consolidation. The deal between Leamington, Ont.'s, Aphria and Nanaimo, B.C.'s, Tilray is aimed at sharing costs.

They want savings of $100-million over the next two years by combining production assets, sales groups and reducing expenses.

Aphria's executives spoke with several potential partners earlier in the year.

In the end, a deal with Tilray made the most sense, chief executive officer Irwin Simon said, because there is not a significant overlap in assets

© 2020 Canjex Publishing Ltd. All rights reserved.

<< Previous
Bullboard Posts
Next >>